PMID: 15344199Sep 3, 2004Paper

Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002

Yonsei Medical Journal
K LeeKorean Natiowide Surveillance of Antimicrobial Resistance Group

Abstract

Continued antimicrobial resistance surveillance can provide valuable information for the empirical selection of antimicrobial agents for patient treatment, and for resistance control. In this 6th annual study for 2002, the susceptibility data at 39 Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) hospitals were analyzed. Resistance rates of S. aureus were 67% to oxacillin, and 58% to clindamycin. The ampicillin and vancomycin resistance rates of E. faecium were 89% and 16%, respectively. To penicillin, 71% of S. pneumoniae were nonsusceptible. Resistance rates of E. coli were 11% to cefotaxime, 8% to cefoxitin, and 34% to fluoroquinolone, and those of K. pneumoniae were 22% to ceftazidime, and 16% to cefoxitin. Lowest resistance rates to cephalosporins shown by E. cloacae and S. marcescens were to cefepime, 7% and 17%, respectively. This is the first KONSAR surveillance, which detected imipenem-resistant E. coli and K. pneumoniae. To imipenem, 22% of P. aeruginosa and 9% of Acinetobacter spp. were resistant. Trends of resistances showed a slight reduction in MRSA and in penicillin- nonsusceptible S. pneumoniae, but an increase in ampicillin-resistant E. faecium. Ampicillin-resistant E. coli and H. influenzae ...Continue Reading

Citations

May 20, 2006·Scandinavian Journal of Infectious Diseases·Hae-Gyung BaeSung Koo Lee
Dec 18, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hiroshi Koganemaru, Shigemi Hitomi
Oct 7, 2008·Pathologie-biologie·C DelamareUNKNOWN CLIN du CHR Metz-Thionville
May 28, 2008·American Journal of Infection Control·Evelina N Lagamayo
Jul 27, 2007·International Journal of Antimicrobial Agents·Kwan Soo KoJae-Hoon Song
Jan 18, 2006·Biochemical Pharmacology·John L Pace, Guang Yang
Mar 22, 2014·Journal of Medical Microbiology·Fateh RahimiMohammad Reza Pourshafie
Jun 14, 2015·International Journal of Antimicrobial Agents·Matthew E FalagasNikolaos S Roussos
Sep 28, 2010·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Sun Kyu LeeSeung Geun Yeo
Jul 19, 2011·Therapeutic Advances in Gastroenterology·Kyoung Sup Hong, Joo Sung Kim
Apr 6, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Kyungwon LeeYunsop Chong
Sep 30, 2005·The Annals of Otology, Rhinology, and Laryngology·Glenn IsaacsonDorothy A Frenz
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Won Sup OhGun-Jo Woo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.